This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Les Laboratoires Servier, Pharmacyclics, Inc.. Active years: 2014.
Company Filing History:
1 out of 295 
1 out of 194 
Years Active: 2014
Title: Renata Robert: Innovator in Cancer Treatment
Introduction
Renata Robert is a notable inventor based in Suresnes, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work has the potential to impact the lives of many patients battling cancer.
Latest Patents
Renata Robert holds a patent for an administration regime involving N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide. This compound is designed for use in cancer treatment, characterized by a specific administration schedule of four consecutive days followed by three days without the compound. The treatment is intended to be used in conjunction with surgery, chemotherapy, or radiotherapy, with the exception of the FOLFOX chemotherapy regimen.
Career Highlights
Throughout her career, Renata has worked with prominent companies in the pharmaceutical industry, including Pharmacyclics, Inc. and Les Laboratoires Servier. Her experience in these organizations has allowed her to develop her expertise in drug formulation and cancer therapies.
Collaborations
Renata has collaborated with talented professionals in her field, including Marylore Chenel and Sriram Balasubramanian. These partnerships have contributed to her innovative approaches in cancer treatment.
Conclusion
Renata Robert is a pioneering inventor whose work in cancer treatment showcases her dedication to improving patient outcomes. Her innovative patent and collaborations highlight her significant contributions to the pharmaceutical industry.